CapOpus
From Wikipedia, the free encyclopedia
CapOpus is the name of a randomized controlled trial (RCT) running in Denmark at Psychiatric Center Bispebjerg (part of Region Hovedstadens Psykiatri) and physically located at Bispebjerg Hospital in Copenhagen. It is an intervention aimed at reducing cannabis consumption in young persons with comorbid schizophrenia and cannabis dependency. It is run by professor, psychiatrist Merete Nordentoft, MD, PhD.
The aim of the RCT is to compare an approach using motivational interviewing, cognitive behaviour therapy, and the stages of change model compared with standard treatment. Among the trial's funders are the Lundbeck foundation, the Municipality of Copenhagen, and Sygekassernes Helsefond.
The trial is, along with the English MIDAS Trial, among the only trials aimed at this particular group of comorbid substance abusers with schizophrenia.
[edit] External links
CapOpus - in both Danish and English
 |
This article about a medical organization or association is a stub. You can help Wikipedia by expanding it. |
 |
This Danish corporation or company article is a stub. You can help Wikipedia by expanding it. |
